Search

Search Constraints

You searched for: Author/Creator Satilmis, Hatice

Search Results

1. Targeting the β2‐adrenergic receptor increases chemosensitivity in multiple myeloma by induction of apoptosis and modulating cancer cell metabolism. Issue 1 (22nd November 2022)

2. Tasquinimod suppresses tumor cell growth and bone resorption by targeting immunosuppressive myeloid cells and inhibiting c-MYC expression in multiple myeloma. Issue 1 (17th January 2023)